Biomedical Engineering Reference
In-Depth Information
Raspadori, D. and D. Damiani, M. Lenoci, D. Rondelli, N. Testoni, G. Nardi, C. Sestigiani,
C. Mariotti, S. Birtolo, M. Tozzi and F. Lauria. 2001. CD56 antigenic expression in
acute myeloid leukemia identii es patients with poor clinical prognosis. Leukemia
15: 1161-1164.
Sackstein, R. and J.S. Merzaban, D.W. Cain, N.M. Dagia, J.A. Spencer, C.P. Lin, and R.
Wohlgemuth. 2008. Ex vivo glycan engineering of CD44 programs human multipotent
mesenchymal stromal cell trai cking to bone. Nat. Med. 14: 181-187.
Santos, F.L.S. and A.I. Dore, A.S.G. Lima, A.B. Garcia, M.A. Zago, E.G. Rizzatti, J. Elias,
Jr., R.P. Falcão and E.M. Rego. 2004. Hematological features and expression proi le of
myeloid antigens of acute promyelocytic leukemia patients. Analysis of prognostic factors
for development of the retinoic acid syndrome. Rev. Assoc. Med. Bras. 50: 286-292.
Spoo, A.C. and M. Lübbert, W.G. Wierda, and J.A. Burger. 2007. CXCR4 is a prognostic
marker in acute myelogenous leukemia. Blood 109: 786-791.
Sugiyama, T. and H. Kohara, M. Noda, and T. Nagasawa. 2006. Maintenance of the
hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow
stromal cell niches. Immunity 25: 977-988.
Tavor, S. and I. Petit, S. Porozov, A. Avigdor, A. Dar, L. Leider-Trejo, N. Shemtov,
V. Deutsch, E. Naparstek, A. Nagler and T. Lapidot. 2004. CXCR4 regulates migration
and development of human acute myelogenous leukemia stem cells in transplanted
NOD/SCID mice. Cancer Res. 64: 2817-2824.
Tien, H.F. and C.H. Wang, M.T. Lin, F.Y. Lee, M.C. Liu, S.M. Chuang, Y.C. Chen, M.C. Shen,
K.H. Lin and D.T. Lin. 1995. Correlation of cytogenetic results with immunophenotype,
genotype, clinical features, and RAS mutation in acute myeloid leukemia. A study of 235
Chinese patients in Taiwan. Cancer Genet. Cytogen. 84: 60-68.
Wang, M.W. and U. Consoli, C.M. Lane, A. Durett, M.J. Lauppe, R. Champlin, M. Andreef
and A.B. Deisseroth. 1998. Rescue from apoptosis in early (CD34-selected) versus late
(non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular
cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells.
Cell Growth Dif er. 9: 105-112.
Zhang, J. and C. Niu, L. Ye, H. Huang, X. He, W.G. Tong, J. Ross, J. Haug, T. Johnson,
J.Q. Feng, S. Harris, L.M. Wiedemann and Y. Mishina and L. Li. 2003. Identii cation
of the haematopoietic stem cell niche and control of the niche size. Nature
425(6960): 836-841.
